Correlation Between Revolution Medicines and Nautilus Biotechnology

Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Nautilus Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Nautilus Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Revolution Medicines and Nautilus Biotechnology, you can compare the effects of market volatilities on Revolution Medicines and Nautilus Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Nautilus Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Nautilus Biotechnology.

Diversification Opportunities for Revolution Medicines and Nautilus Biotechnology

-0.57

Correlation Coefficient

Revolution Medicines  Nautilus Biotechnology

Excellent diversification

The 3 months correlation between Revolution and Nautilus is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Nautilus Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nautilus Biotechnology and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Nautilus Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nautilus Biotechnology has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Nautilus Biotechnology go up and down completely randomly.

Pair Corralation between Revolution Medicines and Nautilus Biotechnology

Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.73 times more return on investment than Nautilus Biotechnology. However, Revolution Medicines is 1.37 times less risky than Nautilus Biotechnology. It trades about 0.13 of its potential returns per unit of risk. Nautilus Biotechnology is currently generating about -0.02 per unit of risk. If you would invest  4,241  in Revolution Medicines on September 4, 2024 and sell it today you would earn a total of  939.00  from holding Revolution Medicines or generate 22.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Revolution Medicines  vs.  Nautilus Biotechnology

Revolution Medicines

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Nautilus Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nautilus Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Nautilus Biotechnology is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Revolution Medicines and Nautilus Biotechnology

The main advantage of trading using opposite Revolution Medicines and Nautilus Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Nautilus Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nautilus Biotechnology will offset losses from the drop in Nautilus Biotechnology's long position.

The idea behind Revolution Medicines and Nautilus Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.